Enovis Corp
and ESAB Corporation Colfax Corporation is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. The Company uses its Colfax Business System, a comprehensive set of tools and processes, to create superior value for customers, shareholders and associates. In March of 2021, Colfax announced its intention to separate into two independent and public companies to accelerate strategic momentum and unlock additional value creation potential. The Company recently announced that it expects to complete the Separation on April 4, 2022 and will then operate under the name Enovis Corporation. Enovis Corporation (NYSE: ENOV) will be an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. ESAB Corporation (NYSE: ESAB) is a world leader in fabrication and specialty gas control technology, providing its partners with advanced equipment, consumables, automation, robotics, and digital solutions which enable the everyday and extraordinary work that shapes our world.
Carries 37.2x more debt than cash on its balance sheet.
Current Price
$23.62
+0.77%GoodMoat Value
$62.36
164.0% undervaluedEnovis Corp (ENOV) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Enovis Corp's financial performance and position as a Industrials company.
Trailing twelve-month (TTM) revenue is $2.25B. Gross profit (TTM) is $1.35B. EBITDA is $-832.95M. Earnings per share (EPS) is $-20.75. The P/E ratio is -1.14. Market capitalization is $1.35B.
Free cash flow (FCF) is $19.92M. FCF growth rate is 6.93%. EPS growth CAGR is 50.00%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Enovis Corp's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.
